Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma
Status:
Active, not recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test any good and bad effects of activity pevonedistat taken
alone, and also to test the safety of pevonedistat in combination with standard chemotherapy,
pemetrexed/cisplatin.